StockData
Sera Prognostics, Inc. logo

Sera Prognostics, Inc. (SERA) stock

SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30
$2.00+0.06 (+3.09%)

Close on Nov 17, 2026Market cap $78.90MP/E –Yield –

Sera Prognostics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Sera Prognostics's revenue for the twelve months ending Jun 30, 2026 was $70.00K, down 35.2% year over year. For fiscal 2025 it was $81.00K, up 5.2% from the year before. The highest annual figure on record is $306.00K in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$81.00K+5.2%
FY2024Dec 31, 2024$77.00K-74.8%
FY2023Dec 31, 2023$306.00K+14.2%
FY2022Dec 31, 2022$268.00K+226.8%
FY2021Dec 31, 2021$82.00K+228.0%
FY2020Dec 31, 2020$25.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$30.00K+76.5%
Q1 FY2026Mar 31, 2026$14.00K-63.2%
Q4 FY2025Dec 31, 2025$10.00K-58.3%
Q3 FY2025Sep 30, 2025$16.00K-44.8%
Q2 FY2025Jun 30, 2025$17.00K-29.2%
Q1 FY2025Mar 31, 2025$38.00K–
Q4 FY2024Dec 31, 2024$24.00K-41.5%
Q3 FY2024Sep 30, 2024$29.00K-31.0%
Q2 FY2024Jun 30, 2024$24.00K-80.5%
Q1 FY2024Mar 31, 2024$0-100.0%
Q4 FY2023Dec 31, 2023$41.00K-36.9%
Q3 FY2023Sep 30, 2023$42.00K-51.7%
Q2 FY2023Jun 30, 2023$123.00K+57.7%
Q1 FY2023Mar 31, 2023$100.00K+163.2%
Q4 FY2022Dec 31, 2022$65.00K+150.0%
Q3 FY2022Sep 30, 2022$87.00K+278.3%
Q2 FY2022Jun 30, 2022$78.00K+290.0%
Q1 FY2022Mar 31, 2022$38.00K+192.3%
Q4 FY2021Dec 31, 2021$26.00K+333.3%
Q3 FY2021Sep 30, 2021$23.00K+360.0%
Q2 FY2021Jun 30, 2021$20.00K+233.3%
Q1 FY2021Mar 31, 2021$13.00K–
Q4 FY2020Dec 31, 2020$6.00K–
Q3 FY2020Sep 30, 2020$5.00K–
Q2 FY2020Jun 30, 2020$6.00K–

More Sera Prognostics figures

See a number that looks wrong?